Key result
Carvedilol did not significantly improve left-ventricular remodeling or function compared with propranolol at 6 months after primary coronary stenting in acute myocardial infarction.
Why the study?
Does carvedilol improve left-ventricular volume and function compared to propranolol in acute MI patients after primary coronary stenting?
Cohort
Does carvedilol improve left-ventricular volume and function compared to propranolol in acute MI patients after primary coronary stenting?
Carvedilol does not provide a significant benefit over propranolol for left-ventricular remodeling or function after primary coronary stenting in acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
No LV remodeling benefit seen with carvedilol versus propranolol post-MI stenting; leaves open optimal beta-blocker choice pending randomized data.
The beneficial effect of beta-blockers is reported in myocardial infarction (MI). This study compared the effects of propranolol and carvedilol on left-ventricular (LV) volume and function after acute MI. Serial echocardiographic studies were performed on acute MI patients who were treated with primary coronary stenting and medical treatment, including propranolol or carvedilol. Determinants of the changes in LV volume and function were identified by regression analyses. At 6 months, there was no significant difference in change in the LV end-diastolic volume between patients receiving 2 beta-blockers. The increase of LV ejection fraction was greater in patients receiving carvedilol. On multivariate analyses, it was found that the kind of beta-blocker had no significant influence on the changes in LV volume or ejection fraction, whereas gender and baseline LV ejection fraction were predictive of change in LV ejection fraction. Compared with propranolol, carvedilol did not have a significant benefit on LV remodeling or function after primary coronary stenting in acute MI.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2008) conducted a cohort in Acute myocardial infarction. Carvedilol vs. Propranolol was evaluated on Change in left-ventricular end-diastolic volume and ejection fraction. Carvedilol did not significantly improve left-ventricular remodeling or function compared with propranolol at 6 months after primary coronary stenting in acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: